Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Moellering

Showing results (31-40 of 235) with videos related to

Pageof 24
Sort By:
The Journal of Antimicrobial Chemotherapy|December 1, 1984
Pharmacokinetics of vancomycinR C Moellering
The American Journal of Medicine|June 30, 1986
Have the new beta-lactams rendered the aminoglycosides obsolete for the treatment of serious nosocomial infections?R C Moellering
The American Journal of Medicine|July 31, 1998
The specter of glycopeptide resistance: current trends and future considerationsR C Moellering
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1990
Interaction between antimicrobial consumption and selection of resistant bacterial strainsR C Moellering
The Journal of Infectious Diseases|February 11, 1992
29th annual meeting of the Infectious Diseases Society of AmericaR C Moellering
The Journal of Antimicrobial Chemotherapy|July 11, 1991
The Garrod Lecture. The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic optionsR C Moellering
Pediatric Infectious Disease|July 1, 1985
Ceftazidime: a new broad spectrum cephalosporinR C Moellering
Drugs|January 1, 1997
Gram-positives towards the year 2000R C Moellering
The Journal of Antimicrobial Chemotherapy|October 8, 1999
Quinupristin/dalfopristin: therapeutic potential for vancomycin-resistant enterococcal infectionsR C Moellering
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 20, 2005
The management of infections due to drug-resistant gram-positive bacteriaR C Moellering
Pageof 24

Showing results (31-40 of 235) with videos related to

Sort By:
Pageof 24
The Journal of Antimicrobial Chemotherapy|December 1, 1984
Pharmacokinetics of vancomycinR C Moellering
The American Journal of Medicine|June 30, 1986
Have the new beta-lactams rendered the aminoglycosides obsolete for the treatment of serious nosocomial infections?R C Moellering
The American Journal of Medicine|July 31, 1998
The specter of glycopeptide resistance: current trends and future considerationsR C Moellering
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1990
Interaction between antimicrobial consumption and selection of resistant bacterial strainsR C Moellering
The Journal of Infectious Diseases|February 11, 1992
29th annual meeting of the Infectious Diseases Society of AmericaR C Moellering
The Journal of Antimicrobial Chemotherapy|July 11, 1991
The Garrod Lecture. The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic optionsR C Moellering
Pediatric Infectious Disease|July 1, 1985
Ceftazidime: a new broad spectrum cephalosporinR C Moellering
Drugs|January 1, 1997
Gram-positives towards the year 2000R C Moellering
The Journal of Antimicrobial Chemotherapy|October 8, 1999
Quinupristin/dalfopristin: therapeutic potential for vancomycin-resistant enterococcal infectionsR C Moellering
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 20, 2005
The management of infections due to drug-resistant gram-positive bacteriaR C Moellering
Pageof 24